Tag: WuXi AppTec

Collaboration of Latvian and Chinese Companies

Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, announced they have entered into a collaboration agreement. Under the agreement...

WuXi AppTec Expands US Facility

WuXi AppTec, headquartered in Shanghai, China, plans to expand its facilities in San Diego. WuXi AppTec describes itself as “a leading global pharmaceutical and medical device open-access capabilit...

WuXi AppTec Raises $1Billion after Debut on SSE

Chinese biotech WuXi AppTec has completed its listing on Hong Kong’s HKEX, raising $967m just months after making its debut on the Shanghai exchange. The company – which provides contract research,...

Schrödinger and Wuxi Apptec formed Faxian Therapeutics

Schrödinger, a privately-held company revolutionizing drug discovery, and WuXi AppTec, a leading pharmaceutical and medical device company, announced that they have formed Faxian Therapeutics.

WuXi AppTec launches a new DNA technology to gear up drug discovery

WuXi AppTec (China), a leading pharmaceutical and medical device technology platform company, launched a new DNA-Encoded Library (DEL) Construction & Screening Platform

WuXi STA will set up a new R&D Center

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), signed an investment agreement with the government of Shanghai Jinshan District to build a new R&D center.

WuXi AppTec launches expanded Laboratory Testing Division in USA

WuXi AppTec, a leading global pharmaceutical and medical device company, announced the opening of its expanded Laboratory Testing Division (LTD) facility in New Jersey.

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the USA

STA Pharmaceutical sees rapid growth in MAH programs in China

STA Pharmaceutical reports that it has seen a rapid uptake in companies with intent to market their products in China

STA Pharmaceutical to open new transition metal catalysis center in Changzhou, China

The center will allow STA to introduce transition metal catalyst-screening technology to existing small molecule process development and manufacturing platform